Ophthalmology Journal

American Academy of Ophthalmology
undefined
Mar 26, 2026 • 25min

Rate and Rationale for Vitrectomy after Pneumatic Retinopexy

Dr. Rajesh Rao interviews Dr. Bradley T. Smith on his study to report the rate and rationale for vitrectomy after retinal detachment repair with pneumatic retinopexy, from his Ophthalmology Retina article, "Rate and Rationale for Vitrectomy after Pneumatic Retinopexy." Rate and Rationale for Vitrectomy after Pneumatic Retinopexy. Smith, Bradley T. et al. Ophthalmology Retina, Volume 9, Issue 11, 1053 – 1061. Looking for ways to give back? By becoming an EyeCare America volunteer, you could help provide eye care to those in your community most in need, from the comfort of your own office. EyeCare America, established by the American Academy of Ophthalmology in 1985 as the first public service program for eye care, connects uninsured and underinsured patients 18 and over in need of medical eye exams with local ophthalmologists. Visit eyecareamerica.org for more info.
undefined
Mar 12, 2026 • 20min

Using AI LLMs For Extracting Eye Exam Findings from EHR Notes

With the current AI boom, physicians are looking for ways to use this new technology in their practices. Dr. Edmund Tsui interviews Dr. Sophia Y. Wang on her Ophthalmology Science article, "Leveraging Large Language Models with Sequential Prompting to Extract Eye Examination Findings from Free-Text Ophthalmology Notes," which showed that LLMs are capable of efficient, automated, and accurate extraction of relevant information from ophthalmology free-text progress notes. Leveraging Large Language Models with Sequential Prompting to Extract Eye Examination Findings from Free-Text Ophthalmology Notes. Ruan, Franklin Y. et al. Ophthalmology Science, Volume 6, Issue 1. If you're working on research right now, consider sharing your latest research at AAO 2026. Abstract submissions for papers, posters, and videos are open now, through April 14. It's a great opportunity to present your work — and connect with colleagues from around the world. Start your submission today at aao.org/pod26.
undefined
Feb 26, 2026 • 24min

Ophthalmology Transfers to an Academic Trauma Center

Dr. Edmund Tsui is joined by Dr. Shu Feng, author of Ophthalmology's Assessing the Efficacy of Ophthalmic Transfers to an Academic Level 1 Trauma Hospital, to discuss her study of ophthalmic transfers to an academic level 1 trauma center and the accuracy of transferring diagnoses and rate of intervention after transfer. Assessing the Efficacy of Ophthalmic Transfers to an Academic Level 1 Trauma Hospital. Hopkin, Blake et al. Ophthalmology, Volume 133, Issue 1, 24 – 30.
undefined
Feb 12, 2026 • 40min

American Glaucoma Society's 40th Anniversary

We're celebrating the American Glaucoma Society's 40th Anniversary! Dr. Emily Schehlein interviews three glaucoma luminaries, previous AGS Presidents, and guest editors for Ophthalmology Glaucoma's AGS 40th Anniversary special issue: Dr. Steven Gedde, Dr. Carla Siegfried, and Dr. Greg Skuta. Together they discuss the past, present, and future of the AGS, advancements in the treatment of glaucoma, and share their personal stories of mentorship and community within the society. Read Ophthalmology Glaucoma's American Glaucoma Society 40th Anniversary supplement issue here: https://www.ophthalmologyglaucoma.org/issue/S2589-4196(25)X0006-5 To find out more about the AGS, how to join, and get involved visit: https://www.americanglaucomasociety.net/home Sign up for the next Ophthalmology Journal Virtual Club on February 25, 2026, at https://store.aao.org/ophthalmology-virtual-journal-club.html
undefined
Jan 29, 2026 • 25min

GLP-1RA Use and Risk of Neovascular AMD

It's our 100th episode! Dr. Rukhsana Mirza sits down with Drs. Aleksandra V. Rachitskaya and Kevin C. Allan to discuss their retrospective study using the TriNetX network to investigate the risk of neovascular age-related macular degeneration (AMD) in patients taking glucagon-like peptide-1 receptor agonists (GLP-1RAs). From their Ophthalmology Retina article, "Glucagon-Like Peptide-1 Receptor Agonist Use and Risk of Neovascular Age-Related Macular Degeneration in a National Cohort Study." Glucagon-Like Peptide-1 Receptor Agonist Use and Risk of Neovascular Age-Related Macular Degeneration in a National Cohort Study. Allan, Kevin C. et al. Ophthalmology Retina. In press Sign up for the next Ophthalmology Journal Virtual Club on February 25, 2026, at https://store.aao.org/ophthalmology-virtual-journal-club.html
undefined
Jan 15, 2026 • 17min

Adalimumab vs. Conventional Immunosuppression for Uveitis

Dr. Edmund Tsui and author Dr. Douglas A. Jabs discuss the results of the ADVISE Trial, designed to compare adalimumab to conventional immunosuppressive drugs for the treatment of non-infectious intermediate, posterior, and panuveitides. From Dr. Jab's Ophthalmology article, "Adalimumab vs. Conventional Immunosuppression for Uveitis (ADVISE) Trial." Adalimumab vs. Conventional Immunosuppression for Uveitis (ADVISE) Trial. Jabs, Douglas A. et al. Ophthalmology. In press. Sign up for the next Ophthalmology Journal Virtual Club on February 25, 2026, at https://store.aao.org/ophthalmology-virtual-journal-club.html
undefined
Dec 18, 2025 • 21min

Age-Related Macular Degeneration and the Gut Microbiome

Our newest host and Social Media Editor, Dr. Rukhsana Mirza, interviews Dr. Phoebe Lin. Together, they discuss Dr. Lin's study on whether an intestinal microbial signature is associated with advanced age-related macular degeneration and the relationship between the microbiota and AMD genetic risk. From her Ophthalmology Science article, "Age-related Eye Disease Studies Supplements and Genetic Risk Score Are Crucial Determinants of Intestinal Microbial Alterations in Advanced Age-Related Macular Degeneration." Dr. Phoebe Lin is an editor for Ophthalmology Science. Age-related Eye Disease Studies Supplements and Genetic Risk Score Are Crucial Determinants of Intestinal Microbial Alterations in Advanced Age-Related Macular Degeneration, Dadgar, Neda et al. Ophthalmology Science, Volume 6, Issue 1.
undefined
Dec 4, 2025 • 16min

Elevated Intraocular Pressure after Cataract Surgery and Risk of Glaucoma

Dr. Emily Schehlein is joined by Dr. Cecilia S. Lee and Dr Parisa Taravati, authors of "Elevated Intraocular Pressure Immediately after Cataract Surgery and Future Risk of Primary Open-Angle Glaucoma in the IRIS® Registry (Intelligent Research in Sight)." Together they discuss the associations between postoperative intraocular pressure after cataract surgery and the future risk of developing primary open-angle glaucoma in patients without prior glaucoma, glaucoma suspect, or ocular hypertension diagnoses. Elevated Intraocular Pressure Immediately after Cataract Surgery and Future Risk of Primary Open-Angle Glaucoma in the IRIS® Registry (Intelligent Research in Sight). Gim, Nayoon et al. Ophthalmology Science, Volume 5, Issue 6.
undefined
Nov 20, 2025 • 18min

Outpatient Oral Doxycycline vs. IV Penicillin for Syphilitic Uveitis

Dr. Edmund Tsui interviews Dr. Brian C. Toy on his retrospective cohort study which shows that oral doxycycline clinical and serologic outcomes are comparable to IV penicillin for syphilitic uveitis, published in Ophthalmology. From "Outpatient Oral Doxycycline versus Intravenous Penicillin for Syphilitic Uveitis." Outpatient Oral Doxycycline versus Intravenous Penicillin for Syphilitic Uveitis. Bao, Yicheng K. et al. Ophthalmology, Volume 132, Issue 12, 1457 - 1459.
undefined
Nov 6, 2025 • 29min

The CorNeat Everpatch and the Process of FDA Authorization

On September 5, 2025, the FDA issued a recall for the CorNeat EverPatch. Dr. Emily Schehlein is joined by Dr. Thomas V. Johnson to discuss his study on the early exposure and surgical revision rates of the CorNeat EverPatch. Later, Dr. Henry Jampel explains the difference between FDA clearance and FDA approval for medical devices. Dr. Johnson coauthored the Ophthalmology article, "Early Postoperative Conjunctival Complications Leading to Exposure of Surgically Implanted CorNeat EverPatch Devices." Dr. Jampel cowrite the accompanying Commentary, "The CorNeat Everpatch and the Process of FDA Authorization." Dr. Henry Jampel is an Associate Editor for Ophthalmology and the Editor-in-Chief for Ophthalmology Glaucoma. Dr. Thomas V. Johnson is an Associate Editor for Ophthalmology Science. Early Postoperative Conjunctival Complications Leading to Exposure of Surgically Implanted CorNeat EverPatch Devices. Kanter, Jacob et al. Ophthalmology, Volume 132, Issue 7, 799 – 814. The CorNeat Everpatch and the Process of FDA Authorization. Jampel, Risa; Jampel, Henry. Ophthalmology, Volume 132, Issue 7, 815 – 816. The Academy's BCSC is your trusted source of clinical knowledge. The 2025-2026 edition includes a major revision to Section 8: External Disease and Cornea. Updates include a new interactive case study on Fuchs endothelial corneal dystrophy and cataracts, as well as 15 new videos of surgical procedures. Advance order Section 8 today at aao.org/BCSC.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app